Pregnolia
Enables to assess accurately the stiffness of the cervical tissue of pregnant and non-pregnant women.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor | €0.0 | round | |
* | €2.3m Valuation: €19.7m | Early VC | |
| Total Funding | 000k | ||
| EUR | 2016 | 2017 | 2018 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| % growth | - | (8 %) | 4 % |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Pregnolia is a Swiss startup that has developed an innovative medical device aimed at improving pregnancy care. The company's flagship product, the Pregnolia System, is designed to measure the stiffness of the cervix, providing a more accurate assessment of cervical status. This device is the culmination of several years of academic research conducted at ETH Zurich and the University Hospital Zurich.
The Pregnolia System supports healthcare professionals in diagnosing conditions related to pregnancy but does not predict the risk of premature birth. By offering a quantitative assessment of the uterine cervix, the device aids in making more informed decisions regarding pregnancy care. This can be particularly valuable for obstetricians and gynecologists who require precise data to manage their patients' health effectively.
Pregnolia primarily serves medical professionals and healthcare institutions that specialize in maternal and prenatal care. The market it operates in is the medical device sector, specifically focusing on pregnancy care and diagnostics. The company's business model revolves around the development, manufacturing, and sale of its medical device. Revenue is generated through the direct sale of the Pregnolia System to healthcare providers and institutions.
The startup has garnered significant recognition, repeatedly making it into the Top 100 Swiss Startup ranking, which underscores its innovative approach and the reliability of its product. The team at Pregnolia combines expertise from scientific, technical, and medical fields, ensuring that the product is both effective and reliable.
In summary, Pregnolia is making strides in the medical device industry with its specialized product aimed at enhancing pregnancy care. By providing a more accurate measurement of cervical stiffness, the company supports healthcare professionals in delivering better care to expectant mothers.
Keywords: Pregnancy care, medical device, cervical stiffness, diagnostics, healthcare, obstetrics, gynecology, Swiss startup, ETH Zurich, University Hospital Zurich.